论文部分内容阅读
目的:观察普米克令舒联合特不他林雾化吸入治疗对小儿哮喘急性发作的临床疗效。方法:将我院自2007年2月～2010年2月住院的90例急性发作的哮喘患者分成两组,普米克令舒联合特不他林雾化吸入50例,对照组用生理盐水加地塞米松加α糜蛋白酶雾化吸入40例,在入院治疗前及治疗后第7天各测一次肺功能进行比较,临床主要症状缓解及住院天数进行比较。结果:普米克令舒联合特不他林组治疗后第7天其肺功能改善、临床主要症状缓解及住院天数与对照组比较,均有统计学意义(P<0.01)。结论:普米克令舒联合特不他林雾化吸入治疗对小儿哮喘急性发作的临床疗效肯定,副作用较少,是治疗小儿哮喘急性发作的一种快捷、高效的方法。
Objective: To observe the clinical effect of Pulmicort respules combined with non-nebulized inhalation on acute asthma attack in children. Methods: Ninety patients with acute exacerbation of asthma who were hospitalized from February 2007 to February 2010 in our hospital were divided into two groups. 50 cases were treated with pulmicort respules combined with terbutaline inhalation, and the control group was treated with saline and dexamethasone Miscell plus α-chymotrypsin inhalation in 40 cases, before admission and after treatment on the 7th day of each measured lung function were compared, the main clinical symptoms and hospitalization days were compared. Results: On the 7th day after the treatment, the pulmonary function improved, the main clinical symptoms relieved and the number of days of hospitalization were significantly higher than those in the control group (P <0.01). Conclusions: The clinical efficacy of pulmicort and shululin combined with non-nebulized inhalation for the treatment of acute asthma in children is affirmative with few side effects. It is a quick and effective method for the treatment of acute asthma in children.